Similar articles

• Management of antiphospholipid syndrome in pregnancy.

  Petri M, Qazi U. Petri M, et al. Rheum Dis Clin North Am. 2006 Aug;32(3):591-607. doi: 10.1016/j.rdc.2006.05.007. Rheum Dis Clin North Am. 2006. PMID: 16880086 Review.
• Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.

  Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G. Triolo G, et al. Arthritis Rheum. 2003 Mar;48(3):728-31. doi: 10.1002/art.10957. Arthritis Rheum. 2003. PMID: 12632426 Clinical Trial.
• Prescribing for thrombophilia--are we going to repeat mistakes of the past?

  Jivraj S. Jivraj S. Gynecol Obstet Invest. 2004;58(4):219; author reply 220. doi: 10.1159/000080418. Epub 2004 Aug 24. Gynecol Obstet Invest. 2004. PMID: 15331855 No abstract available.
• Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).

  Hoppe B, Burmester GR, Dörner T. Hoppe B, et al. Curr Opin Rheumatol. 2011 May;23(3):299-304. doi: 10.1097/BOR.0b013e328344c3f7. Curr Opin Rheumatol. 2011. PMID: 21346577 Review.
• Treatment of antiphospholipid syndrome in pregnancy.

  Cowchock S. Cowchock S. Lupus. 1998;7 Suppl 2:S95-7. doi: 10.1177/096120339800700221. Lupus. 1998. PMID: 9814682 Review.